Singapore, Singapore

Jun Jie Koh

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, Singapore Health Services Pte Ltd, Tan Tock Seng Hospital Pte Ltd. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Antibiotic Development by Jun Jie Koh

Introduction

Jun Jie Koh is an innovative inventor based in Singapore, known for his contributions to the field of antibiotic research. His work focuses on the molecular design of new antibiotics and antibiotic adjuvants, particularly against MCR strains. With a single patent to his name, Koh is making strides in addressing critical health challenges.

Latest Patents

Koh's patent, titled "Molecular design of new antibiotics and antibiotic adjuvants against MCR strains," relates to a compound that comprises a hydrophobic moiety, a linker, and an N-containing moiety. This invention not only details the method of synthesizing the compound but also highlights its potential use as an antibiotic or an adjuvant for existing antibiotics. The patent signifies a step forward in combating antibiotic resistance.

Career Highlights

Throughout his career, Jun Jie Koh has worked with prominent organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Koh has had the opportunity to work alongside talented individuals, including Thet Tun Aung and Jianguo Li. These collaborations have enriched his research and fostered a dynamic environment for innovation.

Conclusion

Jun Jie Koh's work in antibiotic development is crucial in the fight against antibiotic resistance. His innovative approach and dedication to research are paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…